4th Quarter - Report
PENN AVENUE PARTNERS for ALKERMES, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Regulatory and legislative issues impacting Alkermes. S.3593 - Telehealth Extension and Evaluation Act. H.R.2617 - Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY FARRELL HANNEGAN | U.S. General Accounting Office |
| CHRISTINA MCGARRY DAVID | Legislative Assistant/Scheduler, Rep. Mario Diaz-Balart |
| JERR ROSENBAUM | Legislative Director, Sen. John Cornyn; Chief of Staff, Rep. Robert Hurt; Chief of Staff, Rep. Jack Kingston; Chief of Staff, Rep. Virgil Goode |
| JAY SULZMANN | Legislative Director/Health Policy Advisor, Sen. Johnny Isakson; Sr. Policy Advisor/LA/LC/SA, Rep. Wally Herger |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.